Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
31 August 2018 Photo Godfrey Ndoda
UFS Mobile Clinic - an exemplary framework of innovation
Free State Department of Health and the UFS Faculty of Health Sciencesentered into a partnership set to improve primary health care in the Free State society.
The Coordinator of Community Engagement and Rural Health in the Faculty of Health Sciences, Dr René Botha, described the unveiling and handing-over ceremony of the University of the Free State (UFS) Faculty of Health Sciences’ Mobile Clinic as “an auspicious and phenomenal occasion in the history of the faculty, and the institution as a whole”.

This mobile healthcare service will align itself with the current mobile service offered by the Free State Department of Health (FSDH) and will include an optometry service. This is the first service of its kind and aims to expose students and the broader community to mobile primary healthcare on rural platforms.

This collaboration between the Faculty of Health Sciences and the FSDH is believed to change and improve lives.   

“The purpose of the clinic is to enrich current primary healthcare measures that were implemented through valuable collaborations. This will result in the betterment of community members who have limited access to healthcare resources,” explained Dr Botha.

UFS medical students have been working on a continuous healthcare programme that started in 2016. The programme operates in areas in the southern Free State, where students engage with the community, schools, clinics, and are making home visits to residents in the area. The main purpose of the programme is to find solutions to key healthcare problems in the region. 

The MEC of Health, Montseng Tsiu, addressed the audience and explained, “implementing primary healthcare holistically through the mobile clinic, will benefit residents in rural areas who have a lack of facilities”. 

According to Prof Francis Petersen, UFS Rector and Vice-Chancellor, the mobile clinic is an example of the innovation framework that cultivates the university’s mandate. The mandate stipulates the creation and maintenance of equitable partnerships with the province, the FSDH, the Department of Education, and many other crucial stakeholders that will ensure the imparting of knowledge, excellence, and quality in contributing to society.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 
Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept